WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005067952) FORMULATION FOR TREATING OBESITY AND ASSOCIATED METABOLIC SYNDROME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/067952    International Application No.:    PCT/EP2005/000206
Publication Date: 28.07.2005 International Filing Date: 12.01.2005
Chapter 2 Demand Filed:    07.11.2005    
IPC:
A61P 3/04 (2006.01)
Applicants: BRINGWELL INTERNATIONAL AB [SE/SE]; Hovslagargatan 5A, S-111 48 Stockholm (SE) (For All Designated States Except US).
KROTKIEWSKI, Marcin [PL/SE]; (SE) (For US Only)
Inventors: KROTKIEWSKI, Marcin; (SE)
Agent: LAZEWSKI, Marek; Lazewska i Lazewski, Myslowicka 15, PL-01-612 Warsaw (PL)
Priority Data:
P.364411 15.01.2004 PL
Title (EN) FORMULATION FOR TREATING OBESITY AND ASSOCIATED METABOLIC SYNDROME
(FR) FORMULATION DESTINEE AU TRAITEMENT DE L'OBESITE ET DU SYNDROME METABOLIQUE ASSOCIE
Abstract: front page image
(EN)The invention relates to the formulation for treating obesity and associated metabolic syndrome. The formulation is a combination of especially selected vegetable extracts: Green tea extract containing Epigallocatehin galate (EGCG), Coleus forskholii extract, Betula alba extract and Guarana or Yerba Maté extract. According to clinical in vivo and in vitro studies use of formulation of the invention is to be treated as verified method of helping treating all known forms of obesity and associated comorbidities. One of the most important advantages of the formulation of the invention apart from the acceleration of weight loss is the prevention of weight regain after the termination of slimming cure.
(FR)L'invention concerne une formulation destinée au traitement de l'obésité et du syndrome métabolique associé. Cette formulation est une association d'extraits végétaux spécialement sélectionnés: extrait de thé vert contenant l'épigallocatéchine galate (EGCG), extrait de <i>Coleus forskholii </i>, extrait de <i>Betula alba </i>et extrait de Guarana ou de Yerba MatE. Selon des études cliniques <i>in vivo </i>et <i>in vitro </i>, l'utilisation de la formulation de l'invention est à traiter comme méthode vérifiée permettant d'aider au traitement de toutes les formes connues d'obésité et des comorbidités associées. La formulation selon l'invention offre non seulement l'avantage d'une accélération de la perte de poids mais aussi de la prévention d'une reprise pondérale une fois la cure d'amaigrissement terminée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)